Onera Health, an Eindhoven, the Netherlands-based company which specializes in sleep diagnostic and monitoring solutions, raised €30M ($32M) in Series C funding.
The round, which brought the total amount to $55M, was led by EQT Life Sciences and Gimv, with participation from existing investors Innovation Industries, Invest-NL, imec.xpand, BOM, and 15th Rock. As part of this transaction, Drew Burdon, Partner at EQT Life Sciences, and Michaël Vlemmix, Partner at Gimv Life Sciences, will join Onera Health’s Board of Directors.
The company intends to use the funds to accelerate manufacturing and deployment plans to meet the customer demand for its self-applied, no-wire end-to-end solution, and to expedite the clearance of the second generation of its polysomnography (PSG) system in Europe and the United States.
Led by Ruben de Francisco, Founder and CEO, Onera Health specializes in sleep medicine and remote monitoring. Its diagnostic solutions and services aim to help people struggling with sleep-related ailments while also impacting other medical fields by monitoring various chronic conditions, ultimately improving the health and quality of life of patients worldwide. The company’s solutions provide comprehensive sleep test data to physicians in a variety of clinical and non-clinical environments to optimize patient care and reduce healthcare costs.
Onera has offices in the Netherlands and the US.
Commenting on the news, Ruben de Francisco said: “This capital infusion will accelerate our ability to scale in the US and Europe. We will continue aggressively investing in R&D, customer success, and geographic expansion to help the medical field provide the much-needed answers for millions of people affected by sleep disorders. We are incredibly proud and humbled by our success to date and look forward to driving growth together with our new partners.”
FinSMEs
16/01/2024